Literature DB >> 19523868

Development of a reinforced PMMA-based hip spacer adapted to patients' needs.

T Thielen1, S Maas, A Zuerbes, D Waldmann, K Anagnostakos, J Kelm.   

Abstract

Two-stage reimplantation using an interval hip prosthesis (spacer) of antibiotic-impregnated bone cement has become a well-accepted method to eradicate infection and prevent limb shortening. However, custom made as well as prefabricated spacers share a weakness of limited strength and hence several fractures of spacers have been observed, even for partial weight bearing. The purpose of this study was therefore to improve the strength of the custom made spacer, used at the Orthopaedic Department of the Saarland University Hospital (Germany). As the material strength of bone cement is limited, several reinforced spacers with a metal core consisting of titanium grade two have been developed and investigated. Loading procedure was close to the ISO 7206/4, though small adaptation was made. An inserted rod of titanium grade two increased the collapse load up to 1000-1300 N, but considering a maximum expected load of about three times the body weight, still below the required value. A "full-stem" reinforced spacer, i.e. spacer with a titanium endoskeleton and a minimum of 2-3mm PMMA-coating in order to assure drug release, provides a mobile and functional joint through the treatment course. Those with 8mm thickness of titanium endoskeleton endured up to one million load cycles in a load range of 300-2300 N. To give further support for individual cases a meaningful S-N curve for this device was determined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19523868     DOI: 10.1016/j.medengphy.2009.05.004

Source DB:  PubMed          Journal:  Med Eng Phys        ISSN: 1350-4533            Impact factor:   2.242


  9 in total

1.  [Hip joint infections - Results of a questionnaire among 28 university orthopedic departments].

Authors:  K Anagnostakos; D Kohn
Journal:  Orthopade       Date:  2011-09       Impact factor: 1.087

2.  Mechanical complications with one hundred and thirty eight (antibiotic-laden) cement spacers in the treatment of periprosthetic infection after total hip arthroplasty.

Authors:  Martin Faschingbauer; Heiko Reichel; Ralf Bieger; Thomas Kappe
Journal:  Int Orthop       Date:  2015-01-13       Impact factor: 3.075

3.  The effect of endoskeleton on antibiotic impregnated cement spacer for treating deep hip infection.

Authors:  Kuo-Ti Peng; Liang-Tseng Kuo; Wei-Hsiu Hsu; Tsan-Wen Huang; Yao-Hung Tsai
Journal:  BMC Musculoskelet Disord       Date:  2011-01-13       Impact factor: 2.362

4.  Preformed gentamicin spacers in two-stage revision hip arthroplasty: functional results and complications.

Authors:  Christophe Pattyn; Thomas De Geest; Pieter Ackerman; Emmanuel Audenaert
Journal:  Int Orthop       Date:  2010-11-30       Impact factor: 3.075

5.  Mechanical evaluation of hip cement spacer reinforcement with stainless steel Kirschner wires, titanium and carbon rods, and stainless steel mesh.

Authors:  Nobuhiro Kaku; Tomonori Tabata; Hiroshi Tsumura
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-11-25

6.  A Three-Parameter Weibull Distribution Method to Determine the Fracture Property of PMMA Bone Cement.

Authors:  Lielie Li; Hekai Cao; Junfeng Guan; Shuanghua He; Lihua Niu; Huaizhong Liu
Journal:  Polymers (Basel)       Date:  2022-08-30       Impact factor: 4.967

Review 7.  Hip Spacers in Two-Stage Revision for Periprosthetic Joint Infection: A Review of Literature.

Authors:  Alessandro Rava; Matteo Bruzzone; Umberto Cottino; Emilio Enrietti; Roberto Rossi
Journal:  Joints       Date:  2019-10-11

8.  Mechanical behaviour of standardized, endoskeleton-including hip spacers implanted into composite femurs.

Authors:  T Thielen; S Maas; A Zuerbes; D Waldmann; K Anagnostakos; J Kelm
Journal:  Int J Med Sci       Date:  2009-09-03       Impact factor: 3.738

9.  Complications after spacer implantation in the treatment of hip joint infections.

Authors:  Jochen Jung; Nora Verena Schmid; Jens Kelm; Eduard Schmitt; Konstantinos Anagnostakos
Journal:  Int J Med Sci       Date:  2009-09-02       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.